Patents-Review.com
ClassID:

97056 ⎘

C07K14/71 - page 3 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators

Recent Application in this class:
#601
20210187069
2021-06-24

DOMINANT NEGATIVE SARM1 MOLECULES AS A THERAPEUTIC STRATEGY FOR NEURODEGENERATIVE DISEASES OR DISORDERS

 #602
20210177902
2021-06-17

ROR-1 specific chimeric antigen receptors and uses thereof

 #603
20210171645
2021-06-10

Human monoclonal antibodies against EphA4 and their use

 #604
20210171605
2021-06-10

Anti-VEGF protein compositions and methods for producing the same

 #605
20210171570
2021-06-10

Anti-VEGF protein compositions and methods for producing the same

 #606
20210170057
2021-06-10

HER2 binders

 #607
20210170001
2021-06-10

CS1 targeted chimeric antigen receptor-modified T cells

 #608
20210163585
2021-06-03

Antibodies specific for sulfation sites of Wnt pathway proteins

 #609
20210163573
2021-06-03

IDENTIFICATION OF IMMUNOGENIC MHC CLASS II PEPTIDES FOR IMMUNE-BASED THERAPY

 #610
20210163569
2021-06-03

ALK4:ActRIIB heteromultimers and uses thereof

 #611
20210163531
2021-06-03

METHODS FOR MAKING STABLE PROTEIN COMPOSITIONS

 #612
20210163528
2021-06-03

Method of purifying glycosylated protein from host cell galectins and other contaminants

 #613
20210155672
2021-05-27

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS

 #614
20210147508
2021-05-20

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

 #615
20210139583
2021-05-13

Production of engineered T-cells by sleeping beauty transposon coupled with methotrexate selection

 #616
20210139560
2021-05-13

Immunomodulatory fusion proteins

 #617
20210139559
2021-05-13

PASylated VEGFR/PDGFR fusion proteins and their use in therapy

 #618
20210121524
2021-04-29

Use of a VEGF antagonist to treat angiogenic eye disorders

 #619
20210115145
2021-04-22

COMBINATION THERAPY WITH TARGETED TGF-B INHIBITION FOR TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER

 #620
20210115142
2021-04-22

Recombinant protein targeting PD-1 and TGFß

 #621
20210107969
2021-04-15

MOLECULES, COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

 #622
20210107965
2021-04-15

BINDING-TRIGGERED TRANSCRIPTIONAL SWITCHES AND METHODS OF USE THEREOF

 #623
20210094985
2021-04-01

Peptide compositions and methods of use

 #624
20210085753
2021-03-25

Use of a VEGF antagonist to treat angiogenic eye disorders

 #625
20210079059
2021-03-18

Treatment of cancer using GFR alpha-4 chimeric antigen receptor

 #626
20210077624
2021-03-18

Citrate buffered VEGF antagonist formulations

 #627
20210070885
2021-03-11

Bispecific antibody or antibody mixture with common light chains

 #628
20210070868
2021-03-11

Combination of anti-HGFR antibody and HEGFR for the treatment of a tumor and/or metastasis

 #629
20210070826
2021-03-11

Multi-chain chimeric polypeptides and uses thereof

 #630
20210070825
2021-03-11

Multi-chain chimeric polypeptides and uses thereof

 #631
20210061915
2021-03-04

Compositions and methods for treating and preventing inflammation

 #632
20210061881
2021-03-04

CHIMERIC CYTOKINE RECEPTORS COMPRISING TGF BETA BINDING DOMAINS

 #633
20210060123
2021-03-04

Nucleic acids encoding p75NTR neurotrophin binding proteins

 #634
20210040501
2021-02-11

Compositions and methods for enhanced gene expression

 #635
20210040192
2021-02-11

METHOD OF PROMOTING BONE GROWTH BY AN ANTI-ACTRIIA ANTIBODY

 #636
20210032608
2021-02-04

Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders

 #637
20210032607
2021-02-04

Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders

 #638
20210030841
2021-02-04

Activin receptor type IIa variants and methods of use thereof

 #639
20210024612
2021-01-28

PD-L1 binding fibronectin type III domains

 #640
20210024611
2021-01-28

Immunoglobulin complex comprising interleukin-15

 #641
20210023174
2021-01-28

Compositions and methods for treating pulmonary hypertension

 #642
20210023173
2021-01-28

Use of a VEGF antagonist to treat angiogenic eye disorders

 #643
20210023138
2021-01-28

Methods of treating EGFRvIII expressing glioblastomas

 #644
20210010025
2021-01-14

TREATMENT OF OCULAR DISEASES WITH HUMAN POST-TRANSLATIONALLY MODIFIED VEGF-TRAP

 #645
20210009711
2021-01-14

MULTIFUNCTIONAL MOLECULES AND USES THEREOF

 #646
20210009696
2021-01-14

Trispecific antagonists

 #647
20210009657
2021-01-14

SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS

 #648
20210008284
2021-01-14

Pre-filled plastic syringe containing a VEGF antagonist

 #649
20210008188
2021-01-14

Compositions and methods for T cell delivery of therapeutic molecules

 #650
20210002364
2021-01-07

Transgene genetic tags and methods of use

 #651
20210002348
2021-01-07

Antagonists targeting the TGF-β pathway

 #652
20210002342
2021-01-07

BMPRII POLYPEPTIDES AND USES THEREOF

 #653
20200407415
2020-12-31

Activin receptor type IIB variants and methods of use thereof

 #654
20200405835
2020-12-31

FhuD2 fusion proteins for the outer membrane vesicle (OMV) delivery of heterologous polypetides and immunogenic compositions thereof

 #655
20200405814
2020-12-31

Compositions and methods for treating pulmonary hypertension

 #656
20200405640
2020-12-31

Synthetic extracellular vesicles for novel therapies

 #657
20200399379
2020-12-24

FUSION IMMUNOMODULATORY PROTEINS AND METHODS FOR MAKING SAME

 #658
20200398084
2020-12-24

Low energy immune priming for treating cancer and metastasis

 #659
20200397865
2020-12-24

Compositions and methods for treating pulmonary hypertension

 #660
20200397823
2020-12-24

TGF-beta receptors and methods of use

 #661
20200392219
2020-12-17

EXTRACELLULAR VESICLES COMPRISING MEMBRANE-TETHERED TGF-BETA, COMPOSITIONS AND METHODS OF USE THEREOF

 #662
20200390882
2020-12-17

Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform

 #663
20200390860
2020-12-17

Compositions and methods for treating pulmonary hypertension

 #664
20200390807
2020-12-17

COMPOSITION AND METHOD FOR TARGETING NATURAL KILLER CELLS IN IMMUNOTHERAPY TO OVERCOME TUMOR SUPPRESSION WITH MANGANESE DIOXIDE NANOPARTICLES

 #665
20200385812
2020-12-10

FGFR3 FUSION GENE AND PHARMACEUTICAL DRUG TARGETING SAME

 #666
20200384080
2020-12-10

Compositions and methods for treating pulmonary hypertension

 #667
20200377895
2020-12-03

Use of constitutively active variants of growth factor receptors as selection markers for the generation of stable producer cell lines

 #668
20200377571
2020-12-03

MULTISPECIFIC MOLECULES AND USES THEREOF

 #669
20200362015
2020-11-19

METHODS AND COMPOSITIONS USING KLOTHO VARIANT POLYPEPTIDES

 #670
20200359610
2020-11-19

HUMANIZED TRANSGENIC ANIMAL

 #671
20200338177
2020-10-29

Chimeric antigen receptors that bind to SSEA4 and uses thereof

 #672
20200331986
2020-10-22

Vascular endothelial growth factor receptor targeting peptide-elastin fusion polypeptides

 #673
20200325217
2020-10-15

Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor

 #674
20200325212
2020-10-15

Tumor-selective CTLA-4 antagonists

 #675
20200325210
2020-10-15

CYSTEINE ENGINEERED FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES

 #676
20200325208
2020-10-15

VEGFR-antibody light chain fusion protein

 #677
20200323955
2020-10-15

Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptor

 #678
20200300860
2020-09-24

Fusion proteins and methods thereof

 #679
20200299390
2020-09-24

PDGF receptor beta binding polypeptides

 #680
20200299389
2020-09-24

Bifunctional proteins combining checkpoint blockade for targeted therapy

 #681
20200299356
2020-09-24

COMPOSITION COMPRISING RAAV CONTAINING SOLUBLE VEGFR-1 VARIENT CDNA FOR TREATMENT OF MACULAR DEGENERATION

 #682
20200283504
2020-09-10

STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF

 #683
20200277388
2020-09-03

Trispecific antagonists

 #684
20200263130
2020-08-20

Cells expressing recombinant growth factor receptors

 #685
20200262905
2020-08-20

DUAL PDGF/VEGF ANTAGONISTS

 #686
20200261565
2020-08-20

Methods and compositions for producing an adenovirus vector for use with multiple vaccinations

 #687
20200255880
2020-08-13

CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN

 #688
20200255496
2020-08-13

VEGFR-FC FUSION PROTEIN FORMULATIONS

 #689
20200255495
2020-08-13

ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELS

 #690
20200247849
2020-08-06

Peptide agonists and antagonists of TLR4 activation

 #691
20200239544
2020-07-30

MODIFIED EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDES FOR USE IN GENETICALLY-MODIFIED CELLS

 #692
20200237862
2020-07-30

Liquid Formalation of a VEGF Antagonist

 #693
20200231652
2020-07-23

TGF-B-RECEPTOR ECTODOMAIN FUSION MOLECULES AND USES THEREOF

 #694
20200231649
2020-07-23

TCRS SPECIFIC FOR MINOR HISTOCOMPATIBILITY (H) ANTIGEN HA-1 AND USES THEREOF

 #695
20200229406
2020-07-23

Rodents With Conditional ACVR1 Mutant Alleles

 #696
20200222556
2020-07-16

Preparation of therapeutic exosomes using membrane proteins

 #697
20200216562
2020-07-09

Integral membrane protein display on poxvirus extracellular enveloped virions

 #698
20200216546
2020-07-09

Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof

 #699
20200207835
2020-07-02

SRCP1-BASED THERAPY FOR DISEASES ASSOCIATED WITH PROTEIN AGGREGATION

 #700
20200207834
2020-07-02

Gene transfer systems for stem cell engineering

 #701
20200199545
2020-06-25

SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGR3) POLYPEPTIDE FOR USE IN THE PREVENTION OR TREATMENT OF SKELETAL GROWTH RETARDATION DISORDERS

 #702
20200199186
2020-06-25

Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels

 #703
20200190162
2020-06-18

Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof

 #704
20200181272
2020-06-11

Bispecific antagonist comprising a LAG-3 binding domain

 #705
20200181221
2020-06-11

Phosphatidylserine targeting fusion molecules and methods for their use

 #706
20200181218
2020-06-11

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

 #707
20200181217
2020-06-11

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

 #708
20200181214
2020-06-11

Fusion proteins for inhibiting angiogenesis

 #709
20200174003
2020-06-04

Fusion proteins and methods thereof

 #710
20200172623
2020-06-04

Recombinant protein targeting PD-L1 and VEGF

 #711
20200165584
2020-05-28

Ligand binding molecules and uses thereof

 #712
20200164052
2020-05-28

HER2 ANTIGENIC POLYPEPTIDE COMPOSITIONS, AND METHODS FOR THEIR USE IN TREATMENT AND PREVENTION OF CARCINOMAS

 #713
20200164029
2020-05-28

Endoglin peptides to treat fibrotic diseases

 #714
20200157512
2020-05-21

Methods and compositions for reducing serum lipids

 #715
20200157182
2020-05-21

Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides

 #716
20200157181
2020-05-21

Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer

 #717
20200157180
2020-05-21

Fusion protein containing TGF-β receptor and medicinal uses thereof

 #718
20200148788
2020-05-14

Methods for screening compounds for increasing thermogenic adipocytes

 #719
20200148746
2020-05-14

Exosome-based anticancer agent

 #720
20200140520
2020-05-07

IMMUNOSUPPRESSIVE TGF-B SIGNAL CONVERTER

 #721
20200140504
2020-05-07

Peptide for toll-like receptor (TLR) inhibition and pharmaceutical composition comprising same

 #722
20200131554
2020-04-30

CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN

 #723
20200131260
2020-04-30

Angiopoietin 2, VEGF dual antagonists

 #724
20200131246
2020-04-30

VEGF antagonist formulations suitable for intravitreal administration

 #725
20200123566
2020-04-23

MULTIGENE CONSTRUCT FOR IMMUNE-MODULATORY PROTEIN EXPRESSION AND METHODS OF USE

 #726
20200123515
2020-04-23

TGFBetaR2 endonuclease variants, compositions, and methods of use

 #727
20200123201
2020-04-23

Peptide compositions and methods of use

 #728
20200116726
2020-04-16

PANCREATIC CANCER TARGETS AND USES THEREOF

 #729
20200116717
2020-04-16

Compositions and methods for programmable sensing and control through combinatorial molecular interactions

 #730
20200115455
2020-04-16

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

 #731
20200115443
2020-04-16

BI-FUNCTIONAL FUSION PROTEINS AND USES THEREOF

 #732
20200109193
2020-04-09

Methods and compositions for treating ulcers

 #733
20200101157
2020-04-02

VITRO CELL CULTURE METHODS FOR BETA-THALASSEMIA USING ACTIVIN TYPE II RECEPTOR LIGAND TRAPS

 #734
20200101134
2020-04-02

METHODS FOR TREATING MYELOPROLIFERATIVE NEOPLASM-ASSOCIATED MYELOFIBROSIS AND ANEMIA

 #735
20200093906
2020-03-26

Peptides and combination of peptides for use in immunotherapy against various cancers

 #736
20200093860
2020-03-26

Antigen binding receptors specific for mutated Fc domains

 #737
20200087367
2020-03-19

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

 #738
20200078460
2020-03-12

Activatable two-component photosensitizers

 #739
20200078400
2020-03-12

METHODS FOR DETERMINING CAR-T CELLS DOSING

 #740
20200071392
2020-03-05

Methods of treating cancer using bifunctional molecules that target growth factors

 #741
20200071383
2020-03-05

Methods for treating vascular eye disorders with ActRII antagonists

 #742
20200071382
2020-03-05

TGF-BETA SUPERFAMILY HETEROMULTIMERS AND USES THEREOF

 #743
20200071381
2020-03-05

VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR

 #744
20200071374
2020-03-05

Multi-chain chimeric polypeptides and uses thereof

 #745
20200062849
2020-02-27

Combination PDL1 and TGF-beta blockade in patients with HPV+ malignancies

 #746
20200062821
2020-02-27

Ca2+ regulated binding agents

 #747
20200055958
2020-02-20

Anti-angiogenesis fusion protein and uses thereof

 #748
20200055949
2020-02-20

Targeted TGFβ inhibition

 #749
20200055920
2020-02-20

Single-arm type I and type II receptor fusion proteins and uses thereof

 #750
20200055919
2020-02-20

Variant ActRIIB proteins and uses thereof

 #751
20200054725
2020-02-20

Breast and ovarian cancer vaccines

 #752
20200048618
2020-02-13

Cell

 #753
20200048355
2020-02-13

ALK7 ANTAGONISTS AND USES THEREOF

 #754
20200048351
2020-02-13

Fusion constructs and methods of using thereof

 #755
20200040096
2020-02-06

CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE

 #756
20200040053
2020-02-06

Ligands Modified by Circular Permutation as Agonists and Antagonists

 #757
20200038512
2020-02-06

Tumor treatment methods using cells that localize to the tumor

 #758
20200033353
2020-01-30

Fusion proteins and methods thereof

 #759
20200031948
2020-01-30

Fusion proteins (Seldegs) for selectively depleting antigen-specific antibodies and methods of use thereof

 #760
20200031903
2020-01-30

ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS

 #761
20200017572
2020-01-16

VEGF antagonist formulations suitable for intravitreal administration

 #762
20200016199
2020-01-16

METHODS FOR THE TREATMENT OF B CELL MALIGNANCIES USING ADOPTIVE CELL THERAPY

 #763
20200010851
2020-01-09

Compositions and methods for enhanced gene expression

 #764
20200002439
2020-01-02

Trispecific antagonists

 #765
20200002426
2020-01-02

Antitumor antagonists

 #766
20200000902
2020-01-02

Peptides and combination of peptides for use in immunotherapy against various cancers

 #767
20190389932
2019-12-26

Stabilized receptor polypeptides and uses thereof

 #768
20190388539
2019-12-26

Formulations of VEG antagonist fusion proteins and method of manufacturing them

 #769
20190382496
2019-12-19

ACVR2A-specific antibody and method of treatment of muscle atrophy

 #770
20190382465
2019-12-19

Fusion Polypeptides Capable Of Activating Receptors

 #771
20190375854
2019-12-12

MUC16 specific chimeric antigen receptors and uses thereof

 #772
20190375821
2019-12-12

Cancer treatment composition for inhibiting tumor angiogenesis, containing VEGF deep blocker

 #773
20190375820
2019-12-12

ALK7:actriib heteromultimers and uses thereof

 #774
20190375810
2019-12-12

Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species

 #775
20190367929
2019-12-05

CTLA4/PD1 targeted/immunomodulatory fusion proteins

 #776
20190367621
2019-12-05

Chimeric antigen receptors against AXL or ROR2 and methods of use thereof

 #777
20190365851
2019-12-05

Syndecan-2 compositions and methods of use

 #778
20190359989
2019-11-28

FUSION PROTEIN AND APPLICATIONS THEREOF

 #779
20190359718
2019-11-28

Compositions and methods for treating and preventing inflammation

 #780
20190359682
2019-11-28

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

 #781
20190352619
2019-11-21

ACTRIIB-FC POLYNUCLEOTIDES, POLYPEPTIDES, AND COMPOSITIONS

 #782
20190352418
2019-11-21

Anti-CD73 antibodies and methods of use thereof

 #783
20190352374
2019-11-21

NOVEL IGFR_LIKE 2 RECEPTOR AND USES THEREOF

 #784
20190352373
2019-11-21

TGF-ß DECOY RECEPTOR

 #785
20190352368
2019-11-21

IDENTIFICATION OF NOVEL ANTI-FIBROTIC PEPTIDE IN C-TERMINAL REGION OF THE MET RECEPTOR TYROSINE KINASE

 #786
20190345256
2019-11-14

Binding proteins and chimeric antigen receptor T cells targeting GASP-1 granules and uses thereof

 #787
20190345225
2019-11-14

Activin receptor type IIA variants and methods of use thereof

 #788
20190345224
2019-11-14

Gene therapy methods for age-related diseases and conditions

 #789
20190345223
2019-11-14

Fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof

 #790
20190343880
2019-11-14

CHIMERIC ANTIGEN RECEPTOR GENE-MODIFIED LYMPHOCYTE HAVING CYTOCIDAL EFFECT

 #791
20190338028
2019-11-07

CD47-CAR-T cells

 #792
20190330375
2019-10-31

DOSING REGIMENS AND DOSAGE FORMS FOR TARGETED TGF-B INHIBITION

 #793
20190330308
2019-10-31

Modified soluble VEGF receptor-1 genes and vectors for gene therapy

 #794
20190330307
2019-10-31

METHODS FOR TREATING MUSCLE WASTING AND BONE DISEASE USING NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS

 #795
20190328788
2019-10-31

Therapeutic peptides that target TGF-beta interaction

 #796
20190317105
2019-10-17

Method of Identifying Transmembrane Protein-interacting Compounds

 #797
20190309039
2019-10-10

CRYPTIC POLYPEPTIDES AND USES THEREOF

 #798
20190307842
2019-10-10

Methods for treating bone loss using sclerostin peptides

 #799
20190300607
2019-10-03

COMPOSITION CONTAINING ANTI-ROBO4 ANTIBODY AND OTHER AGENTS

 #800
20190298780
2019-10-03

Methods and compositions for treating inflammatory skin disease with recombinant microorganisms

 #801
20190292533
2019-09-26

Inducible chimeric cytokine receptors

 #802
20190292239
2019-09-26

VEGF-binding protein for blockade of angiogenesis

 #803
20190290744
2019-09-26

Chimeric antigen receptors that bind to SSEA4 and uses thereof

 #804
20190284257
2019-09-19

Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide

 #805
20190282663
2019-09-19

Activin receptor type IIa variants and methods of use thereof

 #806
20190276801
2019-09-12

Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection

 #807
20190276556
2019-09-12

Integral membrane protein display on poxvirus extracellular enveloped virions

 #808
20190276529
2019-09-12

Local orbital therapy for thyroid eye disease

 #809
20190276528
2019-09-12

Stable aqueous formulations of aflibercept

 #810
20190269767
2019-09-05

Peptides and combination of peptides for use in immunotherapy against various cancers

 #811
20190263914
2019-08-29

Regulatable chimeric antigen receptor

 #812
20190263912
2019-08-29

Modulation of intestinal epithelial cell differentiation, maintenance and/or function through T cell action

 #813
20190263892
2019-08-29

Fibronectin based scaffold proteins having improved stability

 #814
20190263876
2019-08-29

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

 #815
20190263862
2019-08-29

Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor

 #816
20190262481
2019-08-29

HER2 binders

 #817
20190262444
2019-08-29

Peptides and combination of peptides for use in immunotherapy against various cancers

 #818
20190256927
2019-08-22

Gene mutations and copy number alterations of EGFR, KRAS and MET

 #819
20190255185
2019-08-22

High affinity CXCR4 selective binding conjugate and method for using the same

 #820
20190249163
2019-08-15

Delivery of therapeutic agents by a collagen binding protein

 #821
20190248906
2019-08-15

Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor

 #822
20190248891
2019-08-15

Drug regulated transgene expression

 #823
20190247463
2019-08-15

Use of a VEGF antagonist to treat angiogenic eye disorders

 #824
20190233486
2019-08-01

Methods for treating myelodysplastic syndromes and sideroblastic anemias

 #825
20190225669
2019-07-25

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

 #826
20190225664
2019-07-25

ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS

 #827
20190224314
2019-07-25

Ramp signal generator of image sensor, and image sensor including same

 #828
20190218273
2019-07-18

Nucleic acid encoding angiopoietin-2 specific Tie2 receptor

 #829
20190218272
2019-07-18

ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF

 #830
20190216908
2019-07-18

Adoptive t-cell therapy

 #831
20190211106
2019-07-11

NOVEL EGFR VARIANT

 #832
20190203188
2019-07-04

Fusion proteins and methods thereof

 #833
20190202894
2019-07-04

Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

 #834
20190194610
2019-06-27

METHODS AND COMPOSITIONS FOR IN VIVO TRANSGENESIS

 #835
20190194283
2019-06-27

Immunomodulatory polypeptides and related compositions and methods

 #836
20190194271
2019-06-27

Fusion proteins for inhibiting angiogenesis

 #837
20190192625
2019-06-27

Method for promoting bone growth using activin-actriia antagonists

 #838
20190177432
2019-06-13

Host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 and antibody production

 #839
20190177398
2019-06-13

Chimeric antigen receptors having GITR intracellular domain as co-stimulatory domain

 #840
20190177382
2019-06-13

Vascular endothelial growth factor antagonists

 #841
20190169637
2019-06-06

A METHOD FOR HIGH LEVEL AND STABLE GENE TRANSFER IN LYMPHOCYTES

 #842
20190169621
2019-06-06

Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins

 #843
20190169248
2019-06-06

Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2

 #844
20190161532
2019-05-30

HCMV entry inhibitors

 #845
20190145976
2019-05-16

Nucleic acids encoding antibodies with high affinity for Alpha-Klotho

 #846
20190144872
2019-05-16

Generating targeted sequence diversity in fusion proteins

 #847
20190144537
2019-05-16

Anti-Notch3 antibody

 #848
20190119382
2019-04-25

Polynucleotides encoding bispecific chimeric antigen receptors

 #849
20190117767
2019-04-25

Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab

 #850
20190117750
2019-04-25

Compositions comprising angiogenic factors and methods of use thereof

 #851
20190112388
2019-04-18

Integral membrane protein display on poxvirus extracellular enveloped virions

 #852
20190112386
2019-04-18

Compositions and methods for tumor transduction

 #853
20190112352
2019-04-18

TGF-receptor II isoform, fusion peptide, methods of treatment and methods in vitro

 #854
20190112350
2019-04-18

Peptidic TGF-beta antagonists

 #855
20190106468
2019-04-11

Wnt/sFRP complexes, Wnt-containing compositions, Wnt-expressing cells, and methods of making, purifying, and using same

 #856
20190100570
2019-04-04

ALK4:ActRIIB heteromultimers and uses thereof

 #857
20190062450
2019-02-28

Engineered antigen presenting cells and uses thereof

 #858
20190062402
2019-02-28

ACVR1-FC FUSION PROTEIN, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

 #859
20190062392
2019-02-28

METHODS FOR TREATING FATTY LIVER DISEASE

 #860
20190062375
2019-02-28

Composition for overcoming resistance to EGFR-targeting agent

 #861
20190060429
2019-02-28

Vaccine for the prevention of breast cancer relapse

 #862
20190053473
2019-02-21

Conditional rodent Acvr1 mutant gene

 #863
20190048063
2019-02-14

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION

 #864
20190046609
2019-02-14

Use of a VEGF antagonist to treat angiogenic eye disorders

 #865
20190045760
2019-02-14

Method for making a genetically modified mouse with an inducible ACVR1 mutation that causes ectopic bone formation

 #866
20190031782
2019-01-31

Bispecific antibody or antibody mixture with common light chains

 #867
20190031735
2019-01-31

VEGF antagonist formulations suitable for intravitreal administration

 #868
20190031734
2019-01-31

Compositions and methods for inhibiting Wnt signaling

 #869
20190030123
2019-01-31

Liquid formulation of a VEGF antagonist

 #870
20190025332
2019-01-24

MIC-1 receptor and uses thereof

 #871
20190016770
2019-01-17

COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF

 #872
20190015492
2019-01-17

Peptides and combination of peptides for use in immunotherapy against various cancers

 #873
20190008936
2019-01-10

DNA vaccine for use in pancreatic cancer patients

 #874
20190008902
2019-01-10

METHODS FOR ENHANCED PRODUCTION AND ISOLATION OF CELL-DERIVED VESICLES

 #875
20190000920
2019-01-03

Methods of treating lung cancer

 #876
20180362940
2018-12-20

Expression of novel cell tags

 #877
20180362613
2018-12-20

Inhibitors of the fibroblast growth factor receptor

 #878
20180362603
2018-12-20

Methods and compositions for reducing the immunogenicity of chimeric notch receptors

 #879
20180360937
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

 #880
20180360936
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

 #881
20180360882
2018-12-20

Perispinal perfusion by administration of T regulatory cells alone or in combination with angiogenic cell therapies

 #882
20180355011
2018-12-13

Binding-triggered transcriptional switches and methods of use thereof

 #883
20180353587
2018-12-13

Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof

 #884
20180346876
2018-12-06

Chimeric antigen receptor cell preparation and uses thereof

 #885
20180339018
2018-11-29

Use of a VEGF antagonist to treat angiogenic eye disorders

 #886
20180327477
2018-11-15

Transforming growth factor beta receptor type II fusion polypeptides

 #887
20180326032
2018-11-15

Chimeric antigen receptors targeting HER2

 #888
20180312819
2018-11-01

Protein inhibitors to complement and VEGF pathways and methods of use thereof

 #889
20180311319
2018-11-01

TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS

 #890
20180305438
2018-10-25

BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH

 #891
20180298078
2018-10-18

Method for producing fusion protein having IgG Fc domain

 #892
20180291105
2018-10-11

Anti-Tie2 antibodies and uses thereof

 #893
20180291062
2018-10-11

Peptide compositions and methods of use

 #894
20180280510
2018-10-04

Activatable two-component photosensitizers

 #895
20180273640
2018-09-27

MODIFIED T LYMPHOCYTES HAVING IMPROVED SPECIFICITY

 #896
20180267051
2018-09-20

Method of Identifying Transmembrane Protein-interacting Compounds

 #897
20180265593
2018-09-20

Antibodies and chimeric antigen receptors specific for ROR1

 #898
20180265572
2018-09-20

Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins

 #899
20180263227
2018-09-20

Rodent embryonic stem cell with conditional ACVR1 mutant alleles

 #900
20180256683
2018-09-13

Methods for treating heart failure with a TRKB agonist